Mettler-Toledo International Inc. (NYSE:MTD) Stock Position Increased by Plato Investment Management Ltd

Plato Investment Management Ltd increased its position in Mettler-Toledo International Inc. (NYSE:MTD) by 66.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 585 shares of the medical instruments supplier’s stock after buying an additional 234 shares during the quarter. Plato Investment Management Ltd’s holdings in Mettler-Toledo International were worth $818,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of the company. Bank of New York Mellon Corp grew its stake in shares of Mettler-Toledo International by 169.4% in the 1st quarter. Bank of New York Mellon Corp now owns 573,702 shares of the medical instruments supplier’s stock worth $763,764,000 after purchasing an additional 360,786 shares during the last quarter. Norges Bank bought a new position in shares of Mettler-Toledo International in the fourth quarter valued at $320,847,000. PineStone Asset Management Inc. lifted its position in shares of Mettler-Toledo International by 127.4% during the 2nd quarter. PineStone Asset Management Inc. now owns 259,629 shares of the medical instruments supplier’s stock valued at $362,855,000 after acquiring an additional 145,453 shares during the last quarter. Capital International Investors boosted its stake in shares of Mettler-Toledo International by 15.1% during the 1st quarter. Capital International Investors now owns 1,075,420 shares of the medical instruments supplier’s stock worth $1,431,696,000 after acquiring an additional 141,431 shares in the last quarter. Finally, Corient Private Wealth LLC grew its holdings in shares of Mettler-Toledo International by 854.0% in the 4th quarter. Corient Private Wealth LLC now owns 74,707 shares of the medical instruments supplier’s stock worth $90,617,000 after acquiring an additional 66,876 shares during the last quarter. Institutional investors own 95.07% of the company’s stock.

Insider Activity at Mettler-Toledo International

In other Mettler-Toledo International news, CFO Shawn Vadala sold 250 shares of the company’s stock in a transaction that occurred on Wednesday, August 7th. The stock was sold at an average price of $1,401.00, for a total transaction of $350,250.00. Following the completion of the sale, the chief financial officer now owns 4,914 shares of the company’s stock, valued at $6,884,514. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CFO Shawn Vadala sold 250 shares of the business’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $1,401.00, for a total value of $350,250.00. Following the completion of the sale, the chief financial officer now directly owns 4,914 shares in the company, valued at $6,884,514. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Christian Magloth sold 1,000 shares of the firm’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $1,422.97, for a total transaction of $1,422,970.00. Following the completion of the transaction, the insider now owns 734 shares in the company, valued at $1,044,459.98. The disclosure for this sale can be found here. 1.94% of the stock is owned by company insiders.

Mettler-Toledo International Trading Up 0.7 %

NYSE MTD opened at $1,383.06 on Monday. Mettler-Toledo International Inc. has a 1-year low of $928.49 and a 1-year high of $1,546.93. The firm’s fifty day simple moving average is $1,401.62 and its 200-day simple moving average is $1,371.80. The company has a market capitalization of $29.54 billion, a PE ratio of 38.78, a price-to-earnings-growth ratio of 3.70 and a beta of 1.14.

Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings results on Thursday, August 1st. The medical instruments supplier reported $9.65 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.00 by $0.65. The business had revenue of $946.75 million during the quarter, compared to analyst estimates of $929.13 million. Mettler-Toledo International had a negative return on equity of 575.61% and a net margin of 20.95%. The firm’s revenue was down 3.6% on a year-over-year basis. During the same period in the previous year, the company earned $10.19 EPS. As a group, analysts predict that Mettler-Toledo International Inc. will post 40.35 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on the company. Jefferies Financial Group reaffirmed an “underperform” rating and set a $1,250.00 target price (up from $1,230.00) on shares of Mettler-Toledo International in a report on Monday, June 3rd. Evercore ISI raised their target price on shares of Mettler-Toledo International from $1,375.00 to $1,390.00 and gave the stock an “in-line” rating in a report on Tuesday, July 2nd. StockNews.com upgraded shares of Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Thursday, July 11th. JPMorgan Chase & Co. upped their price target on shares of Mettler-Toledo International from $1,300.00 to $1,400.00 and gave the company a “neutral” rating in a research report on Monday, August 5th. Finally, Wells Fargo & Company assumed coverage on shares of Mettler-Toledo International in a research report on Tuesday, August 27th. They set an “equal weight” rating and a $1,400.00 price objective on the stock. Two analysts have rated the stock with a sell rating, five have issued a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Mettler-Toledo International currently has an average rating of “Hold” and an average target price of $1,356.25.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.Its industrial instruments comprise industrial weighing instruments and related terminals, automatic dimensional measurement and data capture solutions, vehicle scale systems, industrial software, metal detection equipment, x-ray systems, check weighing equipment, camera-based imaging equipment, track-and-trace solutions, and product inspection systems.